Payment overview · 2025
General Payments
$413.47
4 reported records · 2 companies
Healthcare provider profile · identity verified
Win Myint, M.D
Allopathic & Osteopathic Physicians|Internal Medicine · BRONX, NY · NPI 1861460818
Verified facts
What the public records show
CMS Open Payments records show Win Myint, M.D received $413.47 in general payments during 2025 across 4 reported records.
Neurocrine BioSciences, Inc. accounted for 70.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $291.51 | 70.5% | 3 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $121.96 | 29.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $413.47 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $291.51 | 3 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $121.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1448 | 166 |
| Amlodipine Besylate | Amlodipine Besylate | 877 | 101 |
| Eliquis | Apixaban | 744 | 57 |
| Levothyroxine Sodium | Levothyroxine Sodium | 654 | 65 |
| Lisinopril | Lisinopril | 632 | 49 |
| Mirtazapine | Mirtazapine | 573 | 54 |
| Gabapentin | Gabapentin | 569 | 65 |
| Metoprolol Tartrate | Metoprolol Tartrate | 453 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 452 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 380 | 50 |
| Furosemide | Furosemide | 364 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 318 | 32 |
| Donepezil Hcl | Donepezil Hcl | 289 | 33 |
| Memantine Hcl | Memantine Hcl | 287 | 30 |
| Losartan Potassium | Losartan Potassium | 256 | 37 |
| Metformin Hcl | Metformin Hcl | 256 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 229 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 228 | 25 |
| Nifedipine Er | Nifedipine | 212 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 199 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 197 | 23 |
| Latanoprost | Latanoprost | 196 | 35 |
| Pantoprazole Sodium | Pantoprazole Sodium | 193 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 190 | 20 |
| Carvedilol | Carvedilol | 180 | 30 |
| Enulose | Lactulose | 180 | 71 |
| Quetiapine Fumarate | Quetiapine Fumarate | 178 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 163 | 20 |
| Sertraline Hcl | Sertraline Hcl | 162 | 15 |
| Januvia | Sitagliptin Phosphate | 158 | 15 |
| Lactulose | Lactulose | 153 | 30 |
| Famotidine | Famotidine | 148 | 29 |
| Tramadol Hcl | Tramadol Hcl | 146 | 38 |
| Finasteride | Finasteride | 140 | 24 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 136 | suppressed |
| Levetiracetam | Levetiracetam | 134 | 21 |
| Omeprazole | Omeprazole | 126 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 111 | 16 |
| Simvastatin | Simvastatin | 111 | 12 |
| Glipizide | Glipizide | 107 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 101 | 29 |
| Brimonidine Tartrate | Brimonidine Tartrate | 101 | 15 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 99 | 31 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 98 | 22 |
| Spironolactone | Spironolactone | 98 | 11 |
| Entresto | Sacubitril/Valsartan | 89 | 12 |
| Jardiance | Empagliflozin | 86 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 82 | 46 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 80 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 79 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 75 | 18 |
| Albuterol Sulfate | Albuterol Sulfate | 74 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 74 | 11 |
| Xarelto | Rivaroxaban | 73 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 68 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 65 | suppressed |
| Aripiprazole | Aripiprazole | 64 | suppressed |
| Digoxin | Digoxin | 63 | suppressed |
| Levofloxacin | Levofloxacin | 62 | 41 |
| Torsemide | Torsemide | 62 | 11 |
| Nystatin | Nystatin | 60 | 29 |
| Alendronate Sodium | Alendronate Sodium | 59 | suppressed |
| Olanzapine | Olanzapine | 59 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 58 | 28 |
| Enalapril Maleate | Enalapril Maleate | 58 | suppressed |
| Ezetimibe | Ezetimibe | 57 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 57 | suppressed |
| Baclofen | Baclofen | 55 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 55 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 19 |
| Warfarin Sodium | Warfarin Sodium | 54 | suppressed |
| Novolog Flexpen | Insulin Aspart | 52 | suppressed |
| Tradjenta | Linagliptin | 52 | suppressed |
| Azithromycin | Azithromycin | 51 | 27 |
| Metformin Hcl Er | Metformin Hcl | 51 | suppressed |
| Olanzapine Odt | Olanzapine | 51 | suppressed |
| Pregabalin | Pregabalin | 51 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 49 | 12 |
| Allopurinol | Allopurinol | 43 | suppressed |
| Clonazepam | Clonazepam | 43 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 43 | 12 |
| Amantadine | Amantadine Hcl | 42 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 42 | 19 |
| Sevelamer Carbonate | Sevelamer Carbonate | 41 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 40 | suppressed |
| Mupirocin | Mupirocin | 39 | 13 |
| Potassium Chloride | Potassium Chloride | 38 | 25 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 20 |
| Anastrozole | Anastrozole | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 35 | 20 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 34 | 34 |
| Cephalexin | Cephalexin | 34 | 21 |
| Doxazosin Mesylate | Doxazosin Mesylate | 34 | suppressed |
| Risperidone | Risperidone | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 23 |
| Labetalol Hcl | Labetalol Hcl | 33 | suppressed |
| Lorazepam | Lorazepam | 31 | 15 |
| Prednisone | Prednisone | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 12 |
| Trazodone Hcl | Trazodone Hcl | 30 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Ibuprofen | Ibuprofen | 29 | 18 |
| Incruse Ellipta | Umeclidinium Bromide | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | 13 |
| Sodium Chloride | Sodium Chloride 0.45 % | 29 | 18 |
| Vancomycin Hcl | Vancomycin Hcl | 29 | suppressed |
| Calcitriol | Calcitriol | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Primidone | Primidone | 27 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Clonidine | Clonidine | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 26 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 26 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 24 | suppressed |
| Timolol Maleate | Timolol Maleate | 24 | suppressed |
| Lamotrigine | Lamotrigine | 23 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Tivicay | Dolutegravir Sodium | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Nyamyc | Nystatin | 21 | 13 |
| Scopolamine | Scopolamine | 21 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 21 | 13 |
| Zonisamide | Zonisamide | 21 | suppressed |
| Budesonide | Budesonide | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Meloxicam | Meloxicam | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 19 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 19 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 19 | 17 |
| Advair Diskus | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Epogen | Epoetin Alfa | 18 | suppressed |
| Carbamazepine Er | Carbamazepine | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 13 |
| Nitroglycerin | Nitroglycerin | 17 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone Dipropionate | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 12 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Armodafinil | Armodafinil | 11 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Evotaz | Atazanavir Sulfate/Cobicistat | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $413.47 · 4 records | Neurocrine BioSciences, Inc. | INGREZZA, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error